Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case study.
| Autor: | Chow KL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand. Electronic address: keli.chow@gmail.com., Keating PE; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand., O'Donnell JL; Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Pathology [Pathology] 2023 Jun; Vol. 55 (4), pp. 587-590. Date of Electronic Publication: 2022 Oct 31. |
| DOI: | 10.1016/j.pathol.2022.08.013 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect